Stryker Corp. (SYK) Director Ronda E. Stryker Sells 6,000 Shares
Stryker Corp. (NYSE:SYK) Director Ronda E. Stryker sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, November 21st. The stock was sold at an average price of $112.01, for a total value of $672,060.00. Following the transaction, the director now owns 193,142 shares in the company, valued at approximately $21,633,835.42. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Shares of Stryker Corp. (NYSE:SYK) traded up 0.03% during midday trading on Monday, reaching $111.47. The company’s stock had a trading volume of 1,184,242 shares. The stock has a 50-day moving average of $114.21 and a 200 day moving average of $114.92. Stryker Corp. has a 12-month low of $86.68 and a 12-month high of $123.55. The firm has a market capitalization of $41.74 billion, a P/E ratio of 25.37 and a beta of 0.86.
Stryker Corp. (NYSE:SYK) last released its earnings results on Thursday, October 27th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.02. The business earned $2.83 billion during the quarter, compared to analysts’ expectations of $2.81 billion. Stryker Corp. had a net margin of 15.24% and a return on equity of 23.61%. The company’s quarterly revenue was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.25 earnings per share. Equities research analysts predict that Stryker Corp. will post $5.78 EPS for the current fiscal year.
Several hedge funds have recently added to or reduced their stakes in the company. LSV Asset Management bought a new stake in Stryker Corp. during the second quarter worth approximately $107,000. Global X Management Co. LLC boosted its stake in shares of Stryker Corp. by 235.8% in the second quarter. Global X Management Co. LLC now owns 994 shares of the medical technology company’s stock valued at $119,000 after buying an additional 698 shares in the last quarter. Mycio Wealth Partners LLC acquired a new stake in shares of Stryker Corp. during the third quarter valued at about $116,000. Salem Investment Counselors Inc. acquired a new stake in shares of Stryker Corp. during the third quarter valued at about $116,000. Finally, Carroll Financial Associates Inc. boosted its stake in shares of Stryker Corp. by 78.0% in the second quarter. Carroll Financial Associates Inc. now owns 1,086 shares of the medical technology company’s stock valued at $130,000 after buying an additional 476 shares in the last quarter. 73.55% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have weighed in on the company. Canaccord Genuity set a $127.00 target price on Stryker Corp. and gave the stock a “buy” rating in a report on Sunday, October 30th. Oppenheimer Holdings Inc. set a $122.00 price target on Stryker Corp. and gave the stock a “hold” rating in a research report on Sunday, October 30th. Needham & Company LLC reissued a “hold” rating on shares of Stryker Corp. in a research report on Sunday, July 24th. Jefferies Group reissued a “hold” rating and issued a $120.00 price target (up from $113.00) on shares of Stryker Corp. in a research report on Monday, July 25th. Finally, Zacks Investment Research cut Stryker Corp. from a “buy” rating to a “hold” rating in a research report on Monday, November 14th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have issued a buy rating to the stock. Stryker Corp. has a consensus rating of “Buy” and a consensus price target of $122.38.
About Stryker Corp.
Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.
Receive News & Stock Ratings for Stryker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corp. and related stocks with our FREE daily email newsletter.